Evaluation of the Zimbabwe HIV case surveillance pilot project, 2019.


Journal

The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926

Informations de publication

Date de publication:
2020
Historique:
received: 16 08 2020
accepted: 29 09 2020
entrez: 2 4 2021
pubmed: 3 4 2021
medline: 15 4 2021
Statut: epublish

Résumé

Zimbabwe has a high burden of HIV (i.e., estimated 1.3 million HIV-infected and 13.8% HIV incidence in 2017). In 2017, the country developed and implemented a pilot of HIV case surveillance (CS) based on the 2017 World Health Organisation (WHO) person-centred HIV patient monitoring (PM) and case surveillance guidelines. At the end of the pilot phase an evaluation was conducted to inform further steps. The pilot was conducted in two districts (i.e., Umzingwane in Matabeleland South Province and Mutare in Manicaland Province) from August 2017 to December 2018. A mixed-methods cross-sectional study of stakeholders and health facility staff was used to assess the design and operations, performance, usefulness, sustainability, and scalability of the CS system. A total of 13 stakeholders responded to an online questionnaire, while 33 health facility respondents were interviewed in 11 health facilities in the two districts. The HIV CS system was adequately designed for Zimbabwe's context, integrated within existing health information systems at the facility level. However, the training was minimal, and an opportunity to train the data entry clerks in data analysis was missed. The system performed well in terms of surveillance and informatics attributes. However, viral load test results return was a significant problem. The HIV CS system was found useful at the health facility level and should be rolled out in a phased manner, beginning in Manicaland and Matabeleland South provinces. An electronic link needs to be made between the health facilities and the laboratory to reduce viral load test results delays.

Identifiants

pubmed: 33796167
doi: 10.11604/pamj.2020.37.353.25600
pii: PAMJ-37-353
pmc: PMC7992901
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

353

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright: Peter Nsubuga et al.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

J Antimicrob Chemother. 2019 Feb 1;74(2):468-472
pubmed: 30476115
MMWR Recomm Rep. 2001 Jul 27;50(RR-13):1-35; quiz CE1-7
pubmed: 18634202
Annu Rev Public Health. 2017 Mar 20;38:57-79
pubmed: 27992726
MMWR Morb Mortal Wkly Rep. 2019 Nov 29;68(47):1089-1095
pubmed: 31774743
JMIR Public Health Surveill. 2017 Jul 10;3(3):e44
pubmed: 28694240

Auteurs

Peter Nsubuga (P)

Global Public Health Solutions Limited Liability Company, Lilburn, United States.

Simbarashe Mabaya (S)

World Health Organization, Harare, Zimbabwe.

Tsitsi Apollo (T)

Ministry of Health and Child Care, Harare, Zimbabwe.

Ngwarai Sithole (N)

Ministry of Health and Child Care, Harare, Zimbabwe.

Brian Komtenza (B)

Ministry of Health and Child Care, Harare, Zimbabwe.

Takura Matare (T)

Ministry of Health and Child Care, Harare, Zimbabwe.

Anesu Chimwaza (A)

Ministry of Health and Child Care, Harare, Zimbabwe.

Kudakwashe Takarinda (K)

Ministry of Health and Child Care, Harare, Zimbabwe.

Brian Moyo (B)

Ministry of Health and Child Care, Harare, Zimbabwe.

Leon Mbano (L)

Ministry of Health and Child Care, Harare, Zimbabwe.

Regis Choto (R)

Ministry of Health and Child Care, Harare, Zimbabwe.

Thandekile Moyo (T)

Ministry of Health and Child Care, Harare, Zimbabwe.

David Lowrance (D)

World Health Organization,Geneva, Switzerland.

Daniel Low-Beer (D)

World Health Organization,Geneva, Switzerland.

Owen Mugurungi (O)

Ministry of Health and Child Care, Harare, Zimbabwe.

Alex Gasasira (A)

World Health Organization, Harare, Zimbabwe.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH